Imperial College London Featured PhD Programmes
University of Kent Featured PhD Programmes
The Francis Crick Institute Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Cardiff University Featured PhD Programmes
"nhs"×
10 miles

Molecular Biology (nhs) PhD Projects, Programs & Scholarships

We have 14 Molecular Biology (nhs) PhD Projects, Programs & Scholarships

  • "nhs" ×
  • Molecular Biology×
  • clear all
Order by 
Showing 1 to 10 of 14
  Development of a single NGS pipeline using a novel universal virus enrichment panel for the detection and typing of viral pathogens.
  Prof L Scobie, Dr R Gunson
Applications accepted all year round

Funding Type

PhD Type

Project reference number. SHLS19001. Current routine virology diagnostics rely upon serological methods and novel molecular methods such as real time PCR.
  Exploring treatment resistance in mantle cell lymphoma
  Dr C Hutchinson, Prof S Rule
Application Deadline: 27 October 2019

Funding Type

PhD Type

The University of Plymouth’s Faculty of Health. Medicine, Dentistry & Human Sciences is seeking a highly motivated PhD candidate with outstanding abilities and enthusiasm for research.
  (MRC DTP) Exploiting tumour-promoting paracrine signals in solid cancers to turbocharge genetically redirected T cells
  Dr A Hurlstone, Prof R Edmondson
Application Deadline: 15 November 2019

Funding Type

PhD Type

Adoptive cell therapy (ACT) using tumour infiltrating lymphocytes (TILs) or genetically redirected T cells are some of the most promising approaches to emerge recently for the treatment of metastatic disease.
  Developing optogenetic therapies for retinal degeneration
  Prof R Lucas, Dr Nina Milosavljevic
Applications accepted all year round

Funding Type

PhD Type

Retinal degeneration is the leading cause of blindness in developed countries. The new exciting biological approach of optogenetic therapy in which ectopic expression of photosensitive proteins (photopigments) is used to restore photosensitivity, offers a potential breakthrough for treating these conditions.
  Health Opportunity for Patient Empowerment in Gestational Diabetes (HOPE-GDM)
  Research Group: Chemistry and Biosciences
  Prof A M Graham, Prof R Qahwaji, Prof A Locke
Applications accepted all year round

Funding Type

PhD Type

Gestational Diabetes is a temporary condition diagnosed at 24-28 weeks gestation, where the body is unable to maintain normal blood glucose levels due to insulin resistance during pregnancy.
  The epigenetics of Parkinson’s disease: searching for novel drug targets. PhD in Medical Studies (MRC GW4 BioMed DTP)
  Dr A Migdalska-Richards
Application Deadline: 25 November 2019

Funding Type

PhD Type

Supervisory team. Dr Anna Migdalska-Richards, Institute of Clinical Biosciences, College of Medicine and Health, University of Exeter.
  How does the vascular matrix environment influence platelet activation?
  Dr S Calaminus
Application Deadline: 31 March 2020

Funding Type

PhD Type

The platelet is a blood cell that plays a key role in the prevention of bleeding. For platelets to form a clot or thrombus effectively, they must rearrange their actin cytoskeleton to withstand high shear stress from blood flow in the arteries.
  Identification of novel glucose-dependent alterations responsible for vascular dysfunction in Type 2 diabetes.
  Prof Tim Palmer, Dr R Sturmey
Application Deadline: 31 March 2020

Funding Type

PhD Type

Diabetes is a growing global healthcare problem. The majority of people living with diabetes have Type 2 diabetes mellitus (T2DM), characterised by a resistance of the body to the action of insulin.
  Modulation of platelet-mediated innate immune responses in chronic lymphocytic leukaemia
  Dr M Arman
Application Deadline: 31 March 2020

Funding Type

PhD Type

Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia in the Western World. B-cell receptor-induced intracellular signals are critical for the survival of leukaemia cells and disruption of this pathway by the Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib is a highly effective CLL therapy.
  Precision-cut lung slices to investigate the effect of human rhinovirus on cough and airway inflammation
  Dr L Sadofsky
Application Deadline: 31 March 2020

Funding Type

PhD Type

The human Rhinovirus (RV) is the major cause of the common cold. There are no current treatments or vaccines for the virus other than over the counter preparations to alleviate symptoms.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.